Stock BIOBLAST PHARMA LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Bioblast Pharma Ltd Nasdaq

Equities

IL0011319527

Biotechnology & Medical Research

Business Summary

Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Managers

Managers TitleAgeSince
Oren Hershkovitz CEO
 Chief Executive Officer 47 19-11-15
Dror Mevorach FOU
 Founder 68 08-12-31
Shachar Shlosberger DFI
 Director of Finance/CFO 47 15-12-31
Veronique Amor-Baroukh COO
 Chief Operating Officer - -
Sigal Arad HRO
 Human Resources Officer - -
Iris Tavor LAW
 General Counsel - -
Einat Galamidi PRN
 Corporate Officer/Principal - 22-02-21
Oren Elmaliah AUD
 Comptroller/Controller/Auditor 40 17-01-31

Members of the board

Members of the board TitleAgeSince
Shai Novik CHM
 Chairman 58 13-12-31
Avri Havron BRD
 Director/Board Member 76 13-12-31
Brian Schwartz BRD
 Director/Board Member 52 20-11-30
Roger Pomerantz BRD
 Director/Board Member 67 22-05-22
Gili Hart BRD
 Director/Board Member 49 13-12-31
Andrew Singer BRD
 Director/Board Member 53 23-04-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,658,555 18,008,736 ( 87.17 %) 0 87.17 %

Shareholders

NameEquities%Valuation
Kip Global Pharma Ecosystem Private Equity Fund
6.810 %
1,421,326 6.810 % 2 M $
Shai Novik
3.709 %
774,033 3.709 % 1 M $
Dror Mevorach
1.161 %
242,345 1.161 % 329 589 $
Avri Havron
0.8602 %
179,540 0.8602 % 244 174 $
Morgan Stanley Capital Services LLC
0.3455 %
72,120 0.3455 % 98 083 $
Renaissance Technologies LLC
0.3348 %
69,889 0.3348 % 95 049 $
Susquehanna Securities LLC
0.3255 %
67,943 0.3255 % 92 402 $
Citadel Securities GP LLC
0.2660 %
55,525 0.2660 % 75 514 $
KSM Mutual Funds Ltd.
0.2276 %
47,506 0.2276 % 64 608 $
IBI Mutual Funds Management (1978) Ltd.
0.2000 %
41,750 0.2000 % 56 780 $

Company contact information

Enlivex Therapeutics Ltd.

14 Einstein Street

7403618, Ness Ziona

+

http://www.enlivex.com
address Bioblast Pharma Ltd

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+16.45% 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+21.96% 116B
ARGENX SE Stock argenx SE
+23.73% 27.03B
BIONTECH SE Stock BioNTech SE
-20.05% 20.36B
BEIGENE, LTD. Stock BeiGene, Ltd.
-16.28% 15.91B
GENMAB A/S Stock Genmab A/S
-16.52% 16.43B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-44.35% 15.6B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+63.91% 14.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.52% 13.59B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Stock
  5. Company Bioblast Pharma Ltd